Projects

Project overview (since 2010-01-01):

			next >>
Start date	Project	acronym	role	funding	partners
2023-01-01	a research and InNOvation Partnership for enhancing the surveillance and control of mosquito VECtors of emerging arboviruses	INOVEC	participant	1.407.600	22
2022-12-01	Advanced biodiversity monitoring for results-based and effective agricultural policy and transformation	BioMonitor4CAP	participant	6.953.353	23
2022-11-01	Risk AssessmenT InnOvatioN for low-risk pesticides	RATION	participant	6.994.748	22
2022-09-01	Training the next-generation of European GLIOblastoma (translational) researchers, to RESOLVE precision targeting of the brain tumour microenvironment	GLIORESOLVE	participant	2.687.400	21
2022-06-01	Biodiversity Digital Twin for Advanced Modelling, Simulation and Prediction Capabilities	BioDT	participant	11.059.061	22
2022-01-01	FrAmework for ClInicaL trIal participants daTA reutilization for a fully Transparent and Ethical ecosystem	FACILITATE	participant	3.260.000	29
2021-10-01	Optimal treatment for patients with solid tumours in Europe through Artificial intelligence	OPTIMA	participant	10.459.997	39
2021-07-01	Building a reproducible single-cell experimental workflow to capture tumour drug persistence	PERSIST-SEQ	participant	7.057.980	16
2021-06-01	Add medical genetic solutions to RESOLUTE (REsolution)	REsolution	participant	1.000.000	9
2021-06-01	RISK assessment of chemicals integrating HUman centric Next generation Testing strategies promoting the 3Rs	RISK-HUNT3R	participant	22.927.769	38
2021-05-01	Ontology-driven and artificial intelligence-based repeated dose toxicity testing of chemicals for next generation risk assessment	ONTOX	participant	17.211.050	19
2021-03-01	European Network Linking Informatics and Genomics of Helper T cells in Tissues	ENLIGHT-TENplus	participant	4.067.526	15
2021-02-01	Central Repository for Digital Pathology	BIGPICTURE	participant	32.319.825	51
2021-01-01	Establishing international standards in the analysis of patient reported outcomes and health-related quality of life data in cancer clinical trials	SISAQOL-IMI	participant	2.281.840	33
2021-01-01	Accelerating Development and Improving Access to CAR and TCR-engineered T cell therapy	T2EVOLVE	participant	8.728.185	29
2021-01-01	A fully integrated, animal-free, end-to-end modelling approach to oral drug product development	InPharma	participant	3.464.964	11
2021-01-01	Advanced machine learning for Innovative Drug Discovery	AIDD	participant	3.926.573	17
2021-01-01	Drug Absorption in Geriatric Patients and Older People: a training network innovating drug development for the advanced age population	AGePOP	participant	2.790.443	6
2020-11-01	Accelerating Research & Development for Advanced Therapies	ARDAT	participant	11.773.000	34
2020-11-01	Gravitate–Health: Empowering and Equipping Europeans with health information for Active Personal Health Management and Adherence to Treatment	Gravitate-Health	participant	9.280.000	42
2020-10-01	HEALTHCARE ALLIANCE FOR RESOURCEFUL MEDICINES OFFENSIVE AGAINST NEOPLASMS IN HEMATOLOGY – PLUS	HARMONY PLUS	participant	6.715.625	41
2020-09-01	Prioritisation and Risk Evaluation of Medicines in the EnviRonment	PREMIER	participant	4.550.000	25
2020-05-01	EUbOPEN: Enabling and Unlocking biology in the OPEN	EUbOPEN	participant	27.935.000	23
2020-04-01	Corona Accelerated R&D in Europe	CARE	participant	36.559.186	43
2020-01-01	PharmaLedger	PharmaLedger	participant	8.290.694	30
2019-10-01	Immune-Image: Specific Imaging of Immune Cell Dynamics Using Novel Tracer Strategies	Immune-Image	participant	15.000.000	23
2019-09-01	Trials@Home: Center of Excellence – Remote Decentralised Clinical Trials	Trials@Home	participant	19.036.998	33
2019-09-01	Collaboration for innovation: Establishment of a pan-nematode drug development platform	HELP	participant	8.713.395	8
2019-07-01	Health.E Lighthouse Support Initiative	HELoS	participant	499.479	8
2019-06-01	MachinE Learning Ledger Orchestration for Drug DiscoverY	MELLODDY	participant	8.000.000	17
2019-04-01	Connecting digital mobility assessment to clinical outcomes for regulatory and clinical endorsement	MOBILISE-D	participant	25.395.897	35
2019-04-01	Thrombo-inflammation in cardiovascular disease	TICARDIO	participant	3.944.038	10
2019-03-01	EBiSC2 – A sustainable European Bank for induced pluripotent Stem Cells	EBiSC2	participant	4.599.648	18
2019-03-01	Integrated IMMUnoprofiling of large adaptive CANcer patients cohorts	IMMUcan	participant	17.830.000	28
2019-03-01	CARdiomyopathy in type 2 DIAbetes mellitus	CARDIATEAM	participant	6.700.000	21
2019-03-01	A multidisciplinary approach towards sustainable improvement in rare diseases care uniting Europe's top class vascular research to find new treatment strategies for vascular anomalies	V.A. Cure	participant	3.792.136	17
2019-01-01	A European standardization framework for data integration and data-driven in silico models for personalized medicine	EU-STANDS4PM	participant	2.042.411	16
2019-01-01	FAIRplus	FAIRplus	participant	3.996.150	22
2018-12-01	European Screening Centre; Unique Library for Attractive Biology	ESCulab	participant	18.249.993	20
2018-11-01	European Health Data and Evidence Network	EHDEN	participant	14.105.750	22
2018-09-01	Ensuring the future of EUPATI beyond 2020	EFOEUPATI	participant	365.243	12
2018-09-01	Quantitative T cell Immunology and Immunotherapy	QuanTII	participant	3.923.653	11
2018-07-01	Research empowerment on solute carriers (ReSOLUTE)	ReSOLUTE	participant	12.000.000	14
2018-06-01	The GetReal Initiative	GetReal Initiative	participant	1.750.000	17
2018-05-01	conect4children (COllaborative Network for European Clinical Trials For Children)	c4c	participant	67.000.000	47
2018-05-01	Integrated control and sensing platform for biopharmaceutical cultivation process high-throughput development and production	iConsensus	participant	4.700.000	19
2018-05-01	Prostate Cancer DIagnOsis and TreatmeNt Enhancement through the Power of Big Data in EuRope	PIONEER	participant	6.000.000	34
2018-05-01	RustWatch: A European early-warning system for wheat rust diseases	RUSTWATCH	participant	4.999.999	25
2018-04-01	Improving the care of patients suffering from acute or chronic pain	IMI-PainCare	participant	11.225.271	40
2018-03-01	Patients Active in Research and Dialogues for an Improved Generation of Medicines: Advancing meaningful patient engagement in the life cycle of medicines for better health outcomes.	PARADIGM	participant	4.498.931	35
			next >>